2025
SJR Q2
JCR Q4 · 1,6
34 matched articles
SCIE
Journal detail
International Journal of STD and AIDS
- Publisher
- SAGE Publications Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0956462417581052
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,483
- Quartile Q2
- H-Index 82
- Cites/doc 1,44
- Docs (3y) 477
- Cites (3y) 667
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,6
- 5Y JIF 1,5
- JCI 0,35
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q2
- Infectious Diseases Q3
- Pharmacology (medical) Q3
- Public Health, Environmental and Occupational Health Q3
Areas
- Medicine
WoS categories
- Immunology | Infectious Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q4 | 0,483 | 1,6 | 1,5 | 0,35 | Q4 | 82 |
| 2024 | Q2 | Q4 | 0,583 | 1,3 | 1,3 | 0,31 | Q4 | 80 |
| 2023 | Q2 | Q4 | 0,54 | 1,4 | 1,4 | 0,27 | Q4 | 80 |
| 2022 | Q2 | Q4 | 0,471 | 1,4 | 1,4 | 0,24 | Q4 | 80 |
| 2021 | Q2 | Q4 | 0,537 | 1,5 | 1,6 | 0,27 | Q4 | 80 |
| 2020 | Q2 | Q4 | 0,673 | 1,4 | 1,6 | 0,35 | Q4 | 80 |
| 2019 | Q2 | Q4 | 0,738 | 1,4 | 1,4 | 0,41 | Q3 | 80 |
| 2018 | — | Q4 | — | 1,5 | 1,4 | 0,41 | Q3 | — |
| 2017 | Q2 | Q4 | 0,737 | 1,5 | 1,3 | 0,4 | Q4 | 80 |
| 2016 | Q2 | Q4 | 0,648 | 1,4 | 1,3 | — | — | 80 |
| 2015 | Q2 | Q4 | 0,753 | 1,3 | 1,2 | — | — | 80 |
| 2014 | Q2 | Q4 | 0,688 | 1,1 | 1,1 | — | — | 80 |
| 2013 | Q2 | Q4 | 0,628 | 1 | 1,1 | — | — | 80 |
| 2012 | Q2 | Q4 | 0,581 | 1 | 1,1 | — | — | 80 |
| 2011 | Q2 | Q4 | 0,618 | 1,1 | 1,1 | — | — | 80 |
| 2010 | Q2 | Q4 | 0,581 | 1,1 | 1,1 | — | — | 80 |
| 2009 | — | Q4 | — | 1,1 | 1,2 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 1,3 | — | — | — |
| 2007 | — | Q4 | — | 1,3 | 1,5 | — | — | — |
| 2006 | — | Q4 | — | 1,3 | — | — | — | — |
| 2005 | — | Q4 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,5 | — | — | — | — |
| 2003 | — | Q3 | — | 1,4 | — | — | — | — |
| 2002 | — | Q3 | — | 1,4 | — | — | — | — |
| 2001 | — | Q4 | — | 1,1 | — | — | — | — |
| 2000 | — | Q4 | — | 1 | — | — | — | — |
| 1999 | — | Q4 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 1 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q4 | 157/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 112/141 |
| 2024 | IMMUNOLOGY | SCIE | Q4 | Q4 | 159/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 112/137 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q4 | 157/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 108/132 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q4 | 153/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 89/96 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q4 | 155/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 89/95 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 156/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 87/93 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 144/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q4 | Q3 | 84/92 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 139/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q4 | Q3 | 76/89 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q4 | 139/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 73/88 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 137/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q4 | — | 73/84 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 139/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q4 | — | 69/83 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 134/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q4 | — | 71/78 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 131/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q4 | — | 63/72 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 123/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q4 | — | 63/70 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 123/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q4 | — | 60/70 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 118/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q4 | — | 51/58 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 114/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q4 | — | 50/57 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 110/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q4 | — | 45/51 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 99/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q4 | — | 44/50 |
| 2006 | IMMUNOLOGY | SCIE | Q4 | — | 98/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q4 | — | 42/47 |
| 2005 | IMMUNOLOGY | SCIE | Q4 | — | 93/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q4 | — | 38/43 |
| 2004 | IMMUNOLOGY | SCIE | Q3 | — | 80/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q4 | — | 31/41 |
| 2003 | IMMUNOLOGY | SCIE | Q3 | — | 81/114 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q3 | — | 29/41 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 83/119 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q3 | — | 26/38 |
| 2001 | IMMUNOLOGY | SCIE | Q4 | — | 87/114 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q4 | — | 28/37 |
| 2000 | IMMUNOLOGY | SCIE | Q4 | — | 89/116 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q4 | — | 29/36 |
| 1999 | IMMUNOLOGY | SCIE | Q4 | — | 89/115 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q4 | — | 27/35 |
| 1998 | IMMUNOLOGY | SCIE | Q3 | — | 86/120 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q3 | — | 26/36 |
| 1997 | IMMUNOLOGY | SCIE | Q4 | — | 93/117 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q3 | — | 25/34 |